A randomized phase II study of docetaxel alone or in combination with PANVAC™-V (vaccinia) and PANVAC™-F (fowlpox) in patients with metastatic breast cancer (NCI 05-C-0229)

被引:32
作者
Arlen, Philip M. [1 ]
Pazdur, Mary [1 ]
Skarupa, Lisa [1 ]
Rauckhorst, Myrna [1 ]
Gulley, James L. [1 ]
机构
[1] NCI, Tumor Immunol & Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
关键词
chemotherapy; randomized trials; vaccine therapy;
D O I
10.3816/CBC.2006.n.032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:176 / 179
页数:4
相关论文
共 26 条
[1]   MECHANISM OF SYNERGY OF LEVAMISOLE AND FLUOROURACIL - INDUCTION OF HUMAN-LEUKOCYTE ANTIGEN CLASS-I IN A COLORECTAL-CANCER CELL-LINE [J].
ABDALLA, EE ;
BLAIR, GE ;
JONES, RA ;
SUELING, HM ;
JOHNSTON, D .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (07) :489-496
[2]   MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma [J].
Aoki, R ;
Tanaka, S ;
Haruma, K ;
Yoshihara, M ;
Sumii, K ;
Kajiyama, G ;
Shimamoto, F ;
Kohno, N .
DISEASES OF THE COLON & RECTUM, 1998, 41 (10) :1262-1272
[3]  
Aquino A, 1998, CLIN CANCER RES, V4, P2473
[4]  
ARLEN P, 2003, P AN M AM SOC CLIN, V22, pA423
[5]   Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes [J].
Bergmann-Leitner, ES ;
Abrams, SI .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2001, 50 (09) :445-455
[6]   Cellular immunity in breast cancer patients completing taxane treatment [J].
Carson, WE ;
Shapiro, CL ;
Crespin, TR ;
Thornton, LM ;
Andersen, BL .
CLINICAL CANCER RESEARCH, 2004, 10 (10) :3401-3409
[7]   Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy [J].
Fong, L ;
Hou, YF ;
Rivas, A ;
Benike, C ;
Yuen, A ;
Fisher, GA ;
Davis, MM ;
Engleman, EG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (15) :8809-8814
[8]   IMMUNE-RESPONSE TO THE CARCINOEMBRYONIC ANTIGEN IN PATIENTS TREATED WITH AN ANTIIDIOTYPE ANTIBODY VACCINE [J].
FOON, KA ;
CHAKRABORTY, M ;
JOHN, WJ ;
SHERRATT, A ;
KOHLER, H ;
BHATTACHARYACHATTERJEE, M .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :334-342
[9]  
GENDLER SJ, 1990, J BIOL CHEM, V265, P15286
[10]   The immunology and immunotherapy of breast cancer: an update [J].
Hadden, JW .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1999, 21 (02) :79-101